[Inhibition of malignant human neoplasms with L-asparaginase].
D001215:Asparaginase / Q000097:blood / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007106:Immune Sera; D007275:Injections, Intravenous; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy
D007106:Immune Sera; D001215:Asparaginase
Hemmung maligner Neoplasien des Menschen durch L-Asparaginase.